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A B S T R A C T
Introduction: Bone marrow lesions (BMLs) are frequently identified by MRI in the subchondral bone in knee
osteoarthritis (KOA). BMLs are known to be closely associated with joint pain, loss of the cartilage and structural
changes in the subchondral trabecular bone (SCTB). Despite this, understanding of the nature of BMLs at the
trabecular tissue level is incomplete. Thus, we used Raman microspectroscopy to examine the biochemical
properties of SCTB from KOA patients with presence or absence of BMLs (OA-BML, OA No-BML; respectively), in
comparison with age-matched cadaveric non-symptomatic controls (Non-OA CTL).
Methods: Tibial plateau (TP) specimens were collected from 19 KOA arthroplasty patients (6-Male, 13-Female;
aged 56–74 years). BMLs were identified ex-vivo by MRI, using PDFS- and T1-weighted sequences. The KOA
specimens were then categorized into an OA-BML group (n = 12; containing a BML within the medial condyle
only) and an OA No-BML group (n = 7; with no BMLs identified in the TP). The control (CTL) group consisted of
Non-OA cadaveric TP samples with no BMLs and no macroscopic or microscopic evidence of OA-related changes
(n = 8; 5-Male, 3-Female; aged 44–80 years). Confocal Raman microspectroscopy, with high spatial resolution,
was used to quantify the biochemical properties of SCTB tissue of both the medial and the lateral condyle in each
group.
Results: The ratios of peak intensity and integrated area of bone matrix mineral (Phosphate (v1), Phosphate (v2)
and Phosphate (v4)), to surrogates of the organic phase of bone matrix (Amide I, Proline and Amide III), were
calculated. Within the medial compartment, the mineral:organic matrix ratios were significantly lower for OA-
BML, compared to Non-OA CTL. These ratios were also significantly lower for the OA-BML medial compartment,
compared to the OA-BML lateral compartment. There were no group or compartmental differences for
Carbonate:Phosphate (v1, v2 and v4), Amide III (α-helix):Amide III (random-coil), Hydroxyproline:Proline, or
Crystallinity.
Conclusion: As measured by Raman microspectroscopy, SCTB tissue in BML zones in KOA is significantly less
mineralized than the corresponding zones in individuals without OA. These data are consistent with those ob-
tained using other methods (e.g. Fourier transform infrared spectroscopy; FTIR) and with the increased rate of
bone remodeling observed in BML zones. Reduced mineralization may change the biomechanical properties of
the trabecular bone in BMLs and the mechanical interaction between subchondral bone and its overlying car-
tilage, with potential implications for the development and progression of OA.
1. Introduction
Bone marrow lesions (BMLs) are frequently detected by MRI in the
subchondral bone of patients with both early and late stage of knee
osteoarthritis (KOA) (Felson et al., 2003). Although BMLs are pre-
dominantly located in the medial compartment of the knee, in the areas
of known high mechanical overload (Roberts et al., 2018), the etiology
of BMLs is still unknown. BMLs are clinically associated with joint pain
(Felson et al., 2001; Ip et al., 2011), cartilage volume loss (Hunter et al.,
2006; Raynauld et al., 2008), and structural changes within the sub-
chondral trabecular bone (SCTB) (Driban et al., 2013), and therefore
appear to have diagnostic and prognostic value in KOA.
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Histopathological examination of the tissue that comprises BMLs
has found severe bone changes, which include thicker subchondral
plate, increased trabecular volume and more plate-like trabeculae, in-
creased microdamage, and increased evidence of bone remodeling,
with more eroded bone surface and increased non-mineralized osteoid
volume (Muratovic et al., 2016, 2018, 2019). However, the biochem-
istry of the bone within BMLs has received little attention. Only a single
publication reported reduced mineralization in bone cores corre-
sponding to BMLs, when measured using micro-CT (Kazakia et al.,
2013). In recent years, vibrational spectroscopy techniques, such as
Raman spectroscopy (RS) (Kerns et al., 2014; Morris and Mandair,
2011; Pavlou et al., 2018) and Fourier transform infrared spectroscopy
(FTIR) (Kazakia et al., 2013), have emerged as powerful assessment
tools for interrogating the biochemical properties of both human and
animal bone tissue.
Historically, RS was thought to be difficult to perform, however,
developments in the sources such as diode lasers, charge-coupled de-
vices (CCD), small spectrometers, and optics along with interfacing
optical fibres with Raman have made it user-friendly for many analy-
tical applications (Kuhar et al., 2018). RS is a label-free, non-invasive
technique that is performed in reflection mode, meaning that it can be
used to analyze a biological sample without the need to section it. The
method requires minimal sample preparation and is low sensitive to the
presence of water (Morris and Mandair, 2011; Pavlou et al., 2018;
Butler et al., 2016; Esmonde-White, 2014). RS is, therefore, well suited
to the interrogation of fresh bone samples obtained at surgery. As there
are limited studies measuring the biochemical properties of human OA
subchondral bone, particularly in BML zones, we applied confocal
Raman microspectroscopy to interrogate the overall biochemical
properties of trabecular bone tissue within BMLs. Comparisons were
then made between tibial SCTB from late-stage KOA patients with and
without tibial BMLs (OA-BML, OA No-BML; respectively), and age-
matched cadaveric controls (Non-OA CTL) without OA and BMLs.
2. Methods
2.1. Specimen collection and MRI assessment
Tibial plateaus (TP) were obtained from 19 patients aged 56 to
74 years, of whom 6 were males (32%) and 13 were females (68%),
undergoing knee arthroplasty for late-stage OA. The Non-OA group
comprised n = 8 control TP, that were collected from 6 cadavers (two
subjects with bilateral collection; both left and right knee), with no
macroscopic or microscopic signs of KOA, aged 44 to 80 years, of whom
5 were males and 3 were females. Specimens were collected with in-
formed written consent from all patients and with approval from the
Human Research Ethics Committee at the Repatriation General
Hospital, the Royal Adelaide Hospital and The University of Adelaide,
South Australia, in accordance with the Declaration of Helskinki 1975.
Inclusion criteria were: radiographic OA with severe symptomatic dis-
abilities, in particular, severe pain and limited mobility. Exclusion cri-
teria were: secondary OA of the knee due to trauma, rheumatoid ar-
thritis, osteoporosis or evidence of bone-related chronic debilitating
disease.
To identify BMLs, TP were MRI scanned (3 T MRI Siemens TRIO,
Berlin, Germany) ex-vivo, using two specific sequences: fat-suppressed
(FS) proton density-weighted sequences (PDFS) and T1-weighted se-
quences, as described previously (Muratovic et al., 2016, 2018, 2019).
After MRI, KOA samples were categorized into an OA-BML group, in
which BMLs were detected in the medial condyle (n = 12) and OA No-
BML, in which no BML was detected in the TP (n = 7). None of the
cadaveric (Non-OA CTL) control TP (n = 8) had any MRI evidence of
BMLs.
2.2. Radiographic and cartilage assessment of OA
Radiographic evidence of OA severity was assessed according to the
Kellgren and Lawrence (K&L) 0-IV scale grade, by two experienced
assessors (AW and Y-YW) with 5% disagreement. Assessors were
blinded to the presence of BMLs in the knee joint. All retrieved TP were
also examined and graded macroscopically, according to the
Outerbridge classification (Slattery and Kweon, 2018), by two ortho-
paedic surgeons blinded for the presence of BMLs in the tibial tissue.
Both BML and cartilage volume in mm3 were measured directly
from MRI images, using the OsiriX software (Pixmeo-SARL,
Switzerland), with the manual marking and automatic volume ren-
dering function to calculate volume. Assessors Y-RL and DM were
blinded to case identity and the final scores were obtained as the
average score values. The coefficient of variation for the measurement
of BML volume was 2.4%, and for cartilage volume was 2.2%.
2.3. Regional sampling and tissue preparation







































Fig. 1. Image showing the average intensity of the Raman spectra (baseline corrected, normalized) for medial SCTB tissue from all three groups (Non-OA CTL; OA
No-BML and OA-BML).
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subchondral bone), of size 10 mm × 10 mm × 5 mm, were cut from
the area of BML location on the medial condyle, using a low-speed
diamond wheel saw (Model 660, South Bay Technology). Lateral con-
dyle samples, from corresponding locations, were cut into the same size
blocks as a control for intragroup variability analysis. Half of the tissue
block was used for RS and half was decalcified, processed, paraffin
embedded, cut into 5-micron thick sections and stained by Safranin-O/
Fast Green to obtain histological Osteoarthritis Research Society
International (OARSI) grade (Waldstein et al., 2016). OARSI grading
was performed by three assessors (Y-RL, DM and EG), blinded to the
BML status of the samples and with extensive experience in quantitative
histopathology. The intra-class correlation coefficient (ICC) for inter-
observer reproducibility was 0.82 (95% CI 0.80, 0.84).
2.4. Raman spectroscopy
Prior to RS, lipids were removed from the tissue samples, to avoid
the effect of strong light scattering on Raman that can result in lipid
spectral peaks overlying some of the bone matrix spectral peaks, as
previously validated by (Kerns et al., 2014), and with some modifica-
tions (Mansell and Bailey, 1998; Bachra and Fischer, 1968). Briefly,
osteochondral unit tissue samples were washed in 5 ml of acetone for
1 h at room temperature by constant agitation on a roller. The samples
were then rinsed several times in distilled water to remove the acetone
(Kerns et al., 2014).
Spectra were acquired directly from the SCTB (~3 mm below the
cartilage, if present), using a Raman microspectrometer (combines an
optical microscopy and a Raman spectrometer; LabRAM High
Resolution 800 (HORIBA, Jobin-Yvon, France), with DuoScan tech-
nology) which offers advanced confocal imaging capability with high
performance and intuitive simplicity. This device was equipped with an
XYZ motorized stage and a diode 785 nm near-infrared laser (un-po-
larized, to minimize the influence of polarization on band intensities
(Kazanci et al., 2006; Mandair and Morris, 2015; Makowski et al.,
2013), and 100% laser power was used for excitation. A continuous
laser beam was focused onto a micro-meter size spot on the surface of
the SCTB sample, identified through a microscope (Olympus, objective
x50). Calibration was performed at the start of each session, using a
silicon standard with a known Raman band at 520.5 cm−1.
Five spectra, obtained directly from trabecular bone at 2 mm in-
tervals across the entire tissue section, were collected for each sample,
with an integration time of 10 s and three accumulations at each site.
The spectral range was selected from 200 to 2000 cm−1, with a re-
solution of 4 cm−1. Spectra were then baseline corrected, using an
automatic fitting algorithm (mixed Gaussian/Lorentzian functions)
with computational Labspec6 software (HORIBA, Jobin-Yvon, France),
prior to evaluation of physiochemical parameters (Fig. 1) (Penel et al.,
2005; Movasaghi et al., 2007; Frushour and Koenig, 1975; Awonusi
et al., 2007). The Raman instrument settings were adopted from pre-
vious published papers (Nyman et al., 2011; Imbert et al., 2014; Pascart
et al., 2017) and kept constant for all measurements. Tissue samples
were placed in the same positioning of the frontal axis to the micro-
scope installed inside the Raman instrument and kept the same height
distance throughout spectra acquisition to avoid any orientation effects.
The intensity of individual Raman bands (or peaks) cannot be used
alone as an empirical measure of the mineral and organic components
content in bone tissue, due to an irregularity of biological material, and
other optical effects in bone, such as grain size, refractive index, and
surface roughness of the tissue that can strongly influence the band
intensity (Morris and Mandair, 2011; Mandair and Morris, 2015;
Buchwald et al., 2012). It is important to take this into account in the
selection of the band for the calculation of the (individual) intensity
peak ratios or integrated area (under the curve) ratios. In previous
studies, for example, the Phosphate; v1PO4 and the Amide I bands were
strongly dependent on the orientation of the tissue (Gamsjaeger et al.,
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sensitive to an orientation effect, such as the Phosphate; v2PO4, v4PO4
or the Amide III band (Kazanci et al., 2006). We have reported the
relative peak intensity ratios and integrated area ratios, corresponding
to characteristic individual Raman bands observed in the mean spectra
of each group, of select pairs of bands from the Raman spectrum, as
described previously, and shown in Table 1 (Kerns et al., 2014; Nyman
et al., 2011; Buchwald et al., 2012; Gamsjaeger et al., 2010; Dehring
et al., 2006; de Souza et al., 2012; Unal et al., 2018; Turunen et al.,
2011; Lastra Luque et al., 2019).
2.5. Statistical analysis
The patients' demographic characteristics, and cartilage and BML
assessment data were either normally or non-normally distributed
(Shapiro-Wilk). The group differences were calculated using analysis of
variance (ANOVA). For parametric data, ANOVA and the Holm-Sidak
comparison test with single pooled variance, were performed. For non-
parametric data, the Kruskal-Wallis test and Dunn's multiple compar-
ison test were performed. The statistical significance was chosen as
p < 0.05. The analyses were performed using the GraphPad Prism 8
software (GraphPad Software, Inc., USA).
The Raman data were analyzed using the IBM SPSS for windows,
version 25 (SPSS Inc.) statistics program, with analysis performed by an
experienced statistician. After an initial check for normal distribution of
the data (Shapiro-Wilk and Skewness and Kurtosis), and whether
ANOVA is appropriate, linear regression using Generalized Estimating
Equations (GEE) (with an independence working correlation) was used
to model the mean of each (individual) peak ratio or integrated area
(under the curve) ratio. To determine differences between groups and
TP compartments, an interaction term was included in the model ad-
justing for clustering on subject (two possible sides, left and right knee)
and controlling for age, gender and body mass index (BMI), as they are
influential factors for biochemical changes in the tissue. A p-value
of< 0.05 was accepted as significant.
3. Results
3.1. Patient demographics and cartilage analysis
The demographic characteristics of the individual patients, grouped
according to the presence or absence of BMLs in the TP samples, are
summarized in Table 2. There were no significant differences between
the three groups (Non-OA CTL; OA No-BML and OA-BML) in age,
gender or cartilage volume (mm3) for the medial compartment. How-
ever, BMI, K&L grade (of the whole TP), Outerbridge classification (of
the whole TP), cartilage volume (mm3) for the lateral compartment,
and OARSI histological score for the medial and lateral compartments
were all significantly different between the three groups.
The median radiographic K&L and macroscopic Outerbridge clas-
sification scores were all significantly higher for OA-BML compared to
Non-OA CTL (p = 0.0005, p = 0.0002; respectively), and for OA No-
BML compared to Non-OA CTL (p = 0.0066, p = 0.0099; respectively)
(Fig. 2). In the medial and lateral compartments, the OARSI score was
significantly higher for OA-BML compared to Non-OA CTL
(p < 0.0001, p < 0.004; respectively), (Fig. 2). In the lateral com-
partment only, the OARSI score for OA No-BML was significantly higher
than Non-OA CTL. No change in cartilage volume between groups was
observed for the medial compartment. However, in the lateral com-
partment, a reduced cartilage volume was detected in OA-BML com-
pared to Non-OA CTL (p < 0.0001), and OA No-BML compared to
Non-OA CTL (p = 0.002) (Fig. 2).
3.2. Raman assessment (peak ratios)
3.2.1. Group comparison (within compartment)
Within the medial compartment, the mineral:matrix ratios of
Phosphate (v1):Amide I, Proline, Amide III; Phosphate (v2):Amide I,
Proline, Amide III, and Phosphate (v4):Amide I were all significantly
lower for OA-BML compared to Non-OA CTL (p = 0.002, p = 0.014,
p = 0.038, p = 0.004, p = 0.027, p = 0.028, p = 0.002; respectively)
(Fig. 3). No other group differences for the mineral:matrix ratios were
observed. There were no group differences for Carbonate:Phosphate
(v1, v2 and v4), Amide III (α-helix):Amide III (random-coil) (Buchwald
et al., 2012), Hydroxyproline:Proline, or Crystallinity in either the
medial or lateral compartments (refer to supplementary data table).
3.2.2. Medial-lateral comparisons
Comparing the medial to lateral compartments within groups, sig-
nificantly lower mineral:matrix ratio of Phosphate (v1, v2 and
v4):Amide I (p = 0.018, p = 0.013, p = 0.028; respectively) and the
mineral:matrix ratio of Phosphate (v1, v2 and v4):Amide III
(p < 0.0001, p < 0.0001, p < 0.0001, respectively), were found in
the medial compartment of the OA-BML group (Fig. 4). In addition, the
mineral:matrix ratio of Phosphate (v1, v2 and v4):Amide III was sig-
nificantly lower in the Non-OA CTL medial compared to the Non-OA
CTL lateral compartment (p = 0.038, p = 0.015, p = 0.036; respec-
tively) (Fig. 4). There were no compartment differences for any other
peak ratios for each group.
Table 2
Patient demographic characteristics and cartilage assessment.
Patient demographic & cartilage assessment Non-OA CTL (n = 8) OA No-BML (n = 7) OA-BML (n = 12) p-Value
Age (years) 63.8 ± 13.8 69.6 ± 2.6 66.5 ± 5.2 0.4a, 0.8b, 0.7c
Male, number (%) 5.0 (62%) 1.0 (14%) 5.0 (42%) 0.5a, 0.9b, 0.4c
Female, number (%) 3.0 (38%) 6.0 (86%) 7.0 (58%) 0.6a,0.4b, 1.0c
BMI 24.4 (23.3, 25.0) 36.5 (28.3, 40.3) 33.6 (30.2, 39.3) 0.02a, 0.008b, > 1.0c
K&L grade 0.0 (0.0, 0.0) 2.0 (1.0, 3.0) 3.0 (3.0, 3.0) 0.007a, 0.0005b, > 1.0c
Outerbridge classification 0.0 (0.0, 0.0) 3.0 (3.0, 4.0) 4.0 (3.0, 4.0) 0.01a, 0.0002b, > 1.0c
BML medial lesion, number (%) NA NA 12.0 (100%) NA
BML lateral lesion, number (%) NA NA 0.0 (0%) NA
BML volume (mm3) NA NA 0.4 ± 0.3 NA
Cartilage volume (mm3), medial 1.5 ± 0.3 1.4 ± 0.3 1.1 ± 0.4 0.7a, 0.1b, 0.2c
Cartilage volume (mm3), lateral 1.9 ± 0.1 1.5 ± 0.2 1.4 ± 0.2 0.002a, < 0.0001b, 0.4c
OARSI score, medial 0.0 (0.0, 0.0) 3.8 (1.9, 4.4) 5.5 (4.3, 5.9) 0.1a, < 0.0001b, 0.3c
OARSI score, lateral 0.9 ± 0.9 2.5 ± 0.4 2.4 ± 0.7 0.004a, 0.004b, 0.7c
Abbreviations: BMI = body mass index, K&L = Kellgren & Lawrence. Values presented as mean ± standard deviation or median (25th, 75th percentiles).
a Non-OA CTL vs. OA No-BML.
b Non-OA CTL vs. OA-BML.
c OA No-BML vs. OA-BML.
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3.3. Raman assessment (integrated area ratios)
3.3.1. Group comparison (within compartment)
The mineral:matrix integrated area ratio of Phosphate (v1):Amide
III was significantly lower for OA-BML compared to Non-OA CTLs
(p = 0.04) in the medial compartment (Fig. 5-A); with no group dif-
ferences for the lateral compartment. No significant differences were
observed for Carbonate:Phosphate (v2) between groups for either the
medial or lateral compartment (refer to supplementary data table).
3.3.2. Medial-lateral comparisons
Significantly lower mineral:matrix integrated area ratio of
Phosphate (v1 and v2):Amide III was found in the medial compartment
compared to the lateral compartment for OA-BML (p = 0.023,
p = 0.009; respectively) (Fig. 5-B). No other differences were observed.
4. Discussion
In this study we applied Raman microspectroscopy to investigate
the material and biochemical composition properties of SCTB within
BML zones of the TP in human knee OA. The main finding of our study
was the reduced ratio of bone mineral:bone organic matrix in trabe-
cular bone in BML zones of the medial TP for individuals with knee OA,












































































































































































































































































Fig. 2. (A) Radiographic K&L grade (of the whole TP), and macroscopic Outerbridge classification (of the whole TP) are presented as median (25th, 75th percentiles)
and (B) microscopic OARSI score (sub-sampled for medial and lateral) are presented as median (25th, 75th percentiles) for medial and mean ± standard deviation
for lateral, and (C) cartilage volume (mm3) (sub-sampled for medial and lateral) are presented as mean ± standard deviation; p value< 0.05 was considered to be
statistically significant.
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the earlier work of Kerns et al. (Kerns et al., 2014), which used Raman
to investigate the biochemical properties of tibial SCTB in OA, but
without consideration of the presence or absence of BMLs. Those au-
thors were able to discriminate between OA bone and Non-OA CTL
bone, on the basis of their Raman spectra, from either the medial or
lateral SCTB compartment. Because the medial compartment typically
contained more damaged cartilage, while the Raman signals were si-
milar on both sides (unlike our study), they considered that bony
changes precede cartilage degradation and loss or, intriguingly, that
inherent differences exist in the OA bone. Also unlike our study, Kerns
et al. reported increased mineralization of the subchondral bone
(Phosphate:Amide I ratio) in the OA samples, compared with the con-
trols. The reason for these different findings is unknown, but could
relate to the presence or absence of BMLs in the tissue, different patient
populations, or different sample handling and instrumentation settings.
Since multiple spectral peaks in our study demonstrated lower Phos-
phate:Amide ratios, we are confident that our study supports the notion
of reduced mineralization in BMLs compared with control subchondral
tibial bone. Our results are consistent with the reported reduced mi-
neralization in OA bone in general, and OA bone with BMLs, as
demonstrated by other techniques, especially FTIR (Kazakia et al.,
2013). Li and Aspen found reduced ‘material density’ in g/cm3 for
trabeculae in the femoral neck of OA individuals (Li and Aspden, 1997).
Reduced mineralization is also consistent with earlier reports of OA
subchondral bone (Day et al., 2001), and is associated with changes in
collagen structure or amount in OA (Li and Aspden, 1997; Couchourel
et al., 2009), and reduced elastic modulus (Day et al., 2001) and me-
chanical strength of the subchondral bone (Mühlhofer et al., 2009;
Bailey et al., 2004). As already noted, reduced mineralization was re-
ported in subchondral bone corresponding to BML zones, when mea-
sured by micro-CT and FTIR analysis (Kazakia et al., 2013; Hunter
et al., 2009). Finally, our Raman data are supported by similar findings
when we used electron back-scatter analysis of bone mineralization
density distribution in BMLs (Kuliwaba et al., 2019).
Our data showed a significant decrease in the bone mineralization
within the OA-BML zones compared to Non-OA CTLs, in the medial
compartment. Since most BMLs occur on the medial side in KOA, we
chose to examine only medial BMLs. The ratios of Phosphate (v1, v2
and v4): Amide I, Proline and Amide III, and the integrated area ratio of


















































































































































































































































































































































































































Phosphate (v1):Amide I, Proline & Amide III
Phosphate (v2):Amide I, Proline & Amide III
Phosphate (v4):Amide I, Proline & Amide III
Fig. 3. The mineral:matrix peak ratios of Phosphate (v1, v2 and v4):Amide I, Proline and Amide III, within the medial compartment only, showing mean ± standard
deviation; p values< 0.05 were considered to be statistically significant.
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trabecular bone compared to control bone from the corresponding sites.
We interpret the data as demonstrating hypo-mineralization of the bone
matrix within BMLs, and propose several possible causes for this effect.
Firstly, hypo-mineralization could be due to an increased rate of bone
remodeling in BMLs, consistent with our evidence of increased micro-
damage, eroded bone surface, and non-mineralized osteoid volume in
BML bone (Muratovic et al., 2016, 2018, 2019; Burr and Gallant, 2012).
Microdamage and repair may increase bone remodeling in individuals
with OA and, collectively, our data suggest that BML areas of bone
correspond to localized areas of active repair response and remodeling.
Further, increased bone matrix microdamage and altered vasculature in
the SCB of BMLs is consistent with overloading and vascular con-
tributions to the formation of these lesions (Burr and Radin, 2003;
Ruppel et al., 2006). Kazakia et al. used FTIR analysis to investigate
BML zones as pulverized SCTB, and also reported reduced miner-
al:matrix ratios by that method (Kazakia et al., 2013). These authors
obtained evidence of increased bone remodeling in these sites and also
posited this as the cause for their observations (Kazakia et al., 2013).
Secondly, there is evidence that differential expression of collagen
type I α1 and α2 chains results in matrix that is inherently a poorer
substrate for mineralization in OA (Couchourel et al., 2009). Thus, in
vitro studies have shown reduced mineralization by osteoblasts ob-
tained from SCTB in OA (Couchourel et al., 2009) and this associated
with an elevated COL1A1:COL1A2 mRNA ratio, similar to the reported
differential expression of these genes in OA human bone (Truong et al.,
2006). Interestingly, in the light of more recent evidence for a direct
role for TGFβ1 in the development of OA (Zhen et al., 2013), inhibiting
TGFBβ1 in OA osteoblasts corrected the abnormal COL1A1:COL1A2
ratio and increased cell mineralization (Couchourel et al., 2009).
A limitation of this study is that samples were collected from pa-
tients with late-stage knee OA, who presented for total joint replace-
ment surgery, and therefore early SCTB tissue compositional changes of
OA could not be observed. In addition, a relatively small number of
samples were evaluated and further studies with a larger sample size
are indicated.
In summary, our findings show the power of RS to interrogate fresh
tissue samples of subchondral bone in OA, and other disease states. In
this study, we showed that the mineral:matrix properties of OA-BML
SCTB tissue are reduced when compared to Non-OA CTLs, consistent
with demonstrations of hypo-mineralization of subchondral bone in
OA, and particularly in BMLs, as obtained previously using other ana-
lytical methods. That OA-BML SCTB tissue has lower bone miner-
alization is perhaps related to active increased bone remodeling within
BMLs. Changes in mineralization are likely to alter the biomechanical
properties of the SCTB, with potential implications for the overlying
cartilage. These findings further suggest the potential value of ther-
apeutic targeting of the SCTB in OA.
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Phosphate (v1, v2, v4):Amide I
Phosphate (v1, v2, v4):Amide III
Fig. 4. The mineral:matrix peak ratios of Phosphate (v1, v2 and v4):Amide I and Amide III, for compartment differences in each group, showing mean ± standard
deviation; p values< 0.05 were considered to be statistically significant.
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A) Phosphate (v1):Amide III
Fig. 5. The mineral:matrix integrated area ratio of (A) Phosphate (v1):Amide
III, within the medial compartment only, and (B) Phosphate (v1 and v2):Amide
III, for compartment differences in each group, are presented as mean ±
standard deviation, with p values< 0.05 considered to be statistically sig-
nificant.
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